{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T21:02:28Z","timestamp":1782853348422,"version":"3.54.5"},"reference-count":70,"publisher":"American Society of Hematology","issue":"6","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3,24]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Von Willebrand disease (VWD) is the most common inherited bleeding disorder and is often diagnosed in the setting of heavy menstrual bleeding. Because estrogen upregulates von Willebrand factor synthesis, pregnancy and management of menses may influence VWD testing and diagnosis. Throughout the life span, the management of women\u2019s reproductive health is frequently affected by VWD. We seek to describe the interplay between VWD and women\u2019s reproductive health at 3 distinct phases in life: menarche and menstruation, maternal health and fertility, and menopause and aging. Planning for care requires screening for VWD in the setting of reproductive bleeding, counseling patients about expectations, and monitoring for iron deficiency across all 3 phases. Hemostatic plans should be tailored to both factor levels and patient preference. Emphasis is placed on areas lacking vital data.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025016486","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T18:13:51Z","timestamp":1764958431000},"page":"2095-2103","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":2,"title":["The interplay of von Willebrand disease and women\u2019s reproductive health"],"prefix":"10.1182","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0301-7073","authenticated-orcid":false,"given":"Arielle L.","family":"Langer","sequence":"first","affiliation":[{"name":"1Division of Hematology, Brigham and Women\u2019s Hospital, Boston, MA"},{"name":"2Division of Women\u2019s Health, Brigham and Women\u2019s Hospital, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8855-9746","authenticated-orcid":false,"given":"Sarah H.","family":"O\u2019Brien","sequence":"additional","affiliation":[{"name":"3Division of Pediatric Hematology and Oncology, Nationwide Children\u2019s Hospital, The Ohio State University College of Medicine, Columbus, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"issue":"3","key":"2026032411220695400_bib1","first-page":"1065","article-title":"Inconsistency of association between type 1 von Willebrand disease phenotype and genotype in families identified in an epidemiological investigation","volume":"82","author":"Castaman","year":"1999","journal-title":"Thromb Haemost"},{"issue":"2","key":"2026032411220695400_bib2","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood.V69.2.454.454","article-title":"Epidemiological investigation of the prevalence of von Willebrand\u2019s disease","volume":"69","author":"Rodeghiero","year":"1987","journal-title":"Blood"},{"issue":"1","key":"2026032411220695400_bib3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/pbc.22429","article-title":"A prospective evaluation of the prevalence of symptomatic von Willebrand disease (VWD) in a pediatric primary care population","volume":"55","author":"Bowman","year":"2010","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"2026032411220695400_bib4","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0022-3476(05)80384-1","article-title":"Prevalence of von Willebrand disease in children: a multiethnic study","volume":"123","author":"Werner","year":"1993","journal-title":"J Pediatr"},{"issue":"2","key":"2026032411220695400_bib5","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1055\/s-0037-1613992","article-title":"Impact, diagnosis and treatment of von Willebrand disease","volume":"84","author":"Sadler","year":"2000","journal-title":"Thromb Haemost"},{"issue":"1","key":"2026032411220695400_bib6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1538-7836.2009.03661.x","article-title":"The prevalence of symptomatic von Willebrand disease in primary care practice","volume":"8","author":"Bowman","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"3","key":"2026032411220695400_bib7","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/hae.14263","article-title":"Occurrence rates of von Willebrand disease among people receiving care in specialized treatment centres in the United States","volume":"27","author":"Michael Soucie","year":"2021","journal-title":"Haemophilia"},{"issue":"6","key":"2026032411220695400_bib8","doi-asserted-by":"crossref","first-page":"102567","DOI":"10.1016\/j.rpth.2024.102567","article-title":"Predictors of diagnostic delays and loss to follow-up in women with von Willebrand disease: a single-center retrospective cohort study","volume":"8","author":"Shelton","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"issue":"2","key":"2026032411220695400_bib9","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1046\/j.1351-8216.2003.00832.x","article-title":"Trends in clinical management of women with von Willebrand disease: a survey of 75 women enrolled in haemophilia treatment centres in the United States","volume":"10","author":"Kirtava","year":"2004","journal-title":"Haemophilia"},{"issue":"5","key":"2026032411220695400_bib10","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/hae.13292","article-title":"Impact of diagnosis of von Willebrand disease on patient outcomes: analysis of medical insurance claims data","volume":"23","author":"Sidonio","year":"2017","journal-title":"Haemophilia"},{"issue":"20","key":"2026032411220695400_bib11","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1182\/blood-2018-05-848739","article-title":"Evaluation and management of heavy menstrual bleeding in adolescents: the role of the hematologist","volume":"132","author":"O\u2019Brien","year":"2018","journal-title":"Blood"},{"issue":"2","key":"2026032411220695400_bib12","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1365-2141.2009.07610.x","article-title":"Multisite management study of menorrhagia with abnormal laboratory haemostasis: a prospective crossover study of intranasal desmopressin and oral tranexamic acid","volume":"145","author":"Kouides","year":"2009","journal-title":"Br J Haematol"},{"issue":"8","key":"2026032411220695400_bib13","doi-asserted-by":"crossref","first-page":"e612","DOI":"10.1016\/S2352-3026(23)00119-9","article-title":"Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trial","volume":"10","author":"Ragni","year":"2023","journal-title":"Lancet Haematol"},{"issue":"1","key":"2026032411220695400_bib14","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1182\/bloodadvances.2020003264","article-title":"ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease","volume":"5","author":"Connell","year":"2021","journal-title":"Blood Adv"},{"issue":"6","key":"2026032411220695400_bib15","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jpag.2022.07.003","article-title":"Intrauterine device outcomes in young women with heavy menstrual bleeding: comparing patients with and without inherited bleeding disorders","volume":"35","author":"Kendel","year":"2022","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"2","key":"2026032411220695400_bib16","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jpag.2021.11.002","article-title":"Use of the levonorgestrel intrauterine system to treat heavy menstrual bleeding in adolescents and young adults with inherited bleeding disorders and Ehlers-Danlos syndrome","volume":"35","author":"Huguelet","year":"2022","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"2","key":"2026032411220695400_bib17","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jadohealth.2022.02.018","article-title":"Does a bleeding disorder lessen the efficacy of the 52-mg levonorgestrel-releasing intrauterine system for heavy menstrual bleeding in adolescents? A retrospective multicenter study","volume":"71","author":"Khalighi","year":"2022","journal-title":"J Adolesc Health"},{"issue":"4","key":"2026032411220695400_bib18","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jpag.2021.01.014","article-title":"Provider attitudes and practices regarding intrauterine system (IUS) insertion in adolescents with and without bleeding disorders for management of heavy menstrual bleeding","volume":"34","author":"O\u2019Flynn O\u2019Brien","year":"2021","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"10","key":"2026032411220695400_bib19","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1111\/jth.14974","article-title":"Standardizing care to manage bleeding disorders in adolescents with heavy menses-A joint project from the ISTH pediatric\/neonatal and women\u2019s health SSCs","volume":"18","author":"Zia","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2026032411220695400_bib20","doi-asserted-by":"crossref","first-page":"100501","DOI":"10.1016\/j.xagr.2025.100501","article-title":"Efficacy of regular prophylaxis with a plasma-derived von Willebrand factor\/factor VIII concentrate with a 1:1 activity ratio in reducing heavy menstrual bleeding in girls\/women with von Willebrand disease","volume":"5","author":"Kiss","year":"2025","journal-title":"AJOG Glob Rep"},{"issue":"2","key":"2026032411220695400_bib21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ando.2016.04.005","article-title":"Diabetes insipidus and pregnancy","volume":"77","author":"Chanson","year":"2016","journal-title":"Ann Endocrinol (Paris)"},{"issue":"2","key":"2026032411220695400_bib22","first-page":"e13523","article-title":"Diabetes insipidus: pathogenesis, diagnosis, and clinical management","volume":"13","author":"Mutter","year":"2021","journal-title":"Cureus"},{"issue":"2","key":"2026032411220695400_bib23","first-page":"CD009824","article-title":"Desmopressin acetate (DDAVP) for preventing and treating acute bleeds during pregnancy in women with congenital bleeding disorders","volume":"2","author":"Karanth","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"2026032411220695400_bib24","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1182\/blood-2004-11-4472","article-title":"Use of desmopressin (DDAVP) during early pregnancy in factor VIII-deficient women","volume":"105","author":"Mannucci","year":"2005","journal-title":"Blood"},{"issue":"5","key":"2026032411220695400_bib25","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1055\/s-2006-947861","article-title":"Aspects of the laboratory identification of von Willebrand disease in women","volume":"32","author":"Kouides","year":"2006","journal-title":"Semin Thromb Hemost"},{"issue":"3","key":"2026032411220695400_bib26","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0002-9343(82)90729-X","article-title":"Estrogens and surgery in women with von Willebrand\u2019s disease","volume":"73","author":"Alperin","year":"1982","journal-title":"Am J Med"},{"issue":"8","key":"2026032411220695400_bib27","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/00001721-200112000-00009","article-title":"Hypercoagulation in surgical postmenopausal women having hormone replacement with overdose estradiol","volume":"12","author":"He","year":"2001","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"5","key":"2026032411220695400_bib28","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1055\/s-0037-1614855","article-title":"Variations in coagulation factors in women: effects of age, ethnicity, menstrual cycle and combined oral contraceptive","volume":"82","author":"Kadir","year":"1999","journal-title":"Thromb Haemost"},{"issue":"6","key":"2026032411220695400_bib29","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/S0015-0282(02)04285-1","article-title":"Effects of vaginally administered high estradiol doses on hormonal pharmacokinetics and hemostasis in postmenopausal women","volume":"78","author":"Hall","year":"2002","journal-title":"Fertil Steril"},{"issue":"6","key":"2026032411220695400_bib30","first-page":"631","article-title":"Effects of two low-dose oral contraceptives on circulating components of the coagulation and fibrinolytic systems","volume":"109","author":"Gevers Leuven","year":"1987","journal-title":"J Lab Clin Med"},{"issue":"8","key":"2026032411220695400_bib31","first-page":"725","article-title":"Influence of triphasic oral contraceptives on blood rheology and hemostatic and metabolic patterns in young women. Results of a three-year study","volume":"37","author":"Solerte","year":"1992","journal-title":"J Reprod Med"},{"issue":"1","key":"2026032411220695400_bib32","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1177\/107602969900500112","article-title":"Effects on hemostasis after two-year use of low dose combined oral contraceptives with gestodene or levonorgestrel","volume":"5","author":"Prasad","year":"1999","journal-title":"Clin Appl Thromb Hemost"},{"issue":"4","key":"2026032411220695400_bib33","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1538-7836.2006.01847.x","article-title":"A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD)","volume":"4","author":"Tosetto","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"4","key":"2026032411220695400_bib34","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1365-2141.2000.02507.x","article-title":"Clinical manifestations and complications of childbirth and replacement therapy in 385 Iranian patients with type 3 von Willebrand disease","volume":"111","author":"Lak","year":"2000","journal-title":"Br J Haematol"},{"issue":"6","key":"2026032411220695400_bib35","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/j.1538-7836.2007.02563.x","article-title":"Bleeding events and other complications during pregnancy and childbirth in women with von Willebrand disease","volume":"5","author":"James","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"6","key":"2026032411220695400_bib36","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1111\/j.1365-2516.2009.02072.x","article-title":"Gynaecological and obstetrical problems in women with different bleeding disorders","volume":"15","author":"Siboni","year":"2009","journal-title":"Haemophilia"},{"issue":"2","key":"2026032411220695400_bib37","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/hae.14922","article-title":"Impact of inherited bleeding disorders on maternal bleeding and other pregnancy outcomes: a population-based cohort study","volume":"30","author":"Alam","year":"2024","journal-title":"Haemophilia"},{"issue":"1","key":"2026032411220695400_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijgo.15446","article-title":"FIGO preconception checklist: preconception care for mother and baby","volume":"165","author":"Benedetto","year":"2024","journal-title":"Int J Gynaecol Obstet"},{"key":"2026032411220695400_bib39","doi-asserted-by":"crossref","first-page":"100107","DOI":"10.1016\/j.tru.2022.100107","article-title":"Update on pregnancy-associated venous thromboembolism","volume":"8","author":"Langer","year":"2022","journal-title":"Thromb Update"},{"issue":"suppl 1","key":"2026032411220695400_bib40","doi-asserted-by":"crossref","first-page":"5499","DOI":"10.1182\/blood-2023-188011","article-title":"Trend in von Willebrand factor profile in women with von Willebrand disease during pregnancy and postpartum","volume":"142","author":"Albusoul","year":"2023","journal-title":"Blood"},{"issue":"1","key":"2026032411220695400_bib41","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/hae.12568","article-title":"Postpartum von Willebrand factor levels in women with and without von Willebrand disease and implications for prophylaxis","volume":"21","author":"James","year":"2015","journal-title":"Haemophilia"},{"issue":"2","key":"2026032411220695400_bib42","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2516.2011.02625.x","article-title":"Changes in the levels of factor VIII and von Willebrand factor in the puerperium","volume":"18","author":"Huq","year":"2012","journal-title":"Haemophilia"},{"issue":"19","key":"2026032411220695400_bib43","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1182\/blood.2019000964","article-title":"How I manage pregnancy in carriers of hemophilia and patients with von Willebrand disease","volume":"136","author":"Leebeek","year":"2020","journal-title":"Blood"},{"issue":"2","key":"2026032411220695400_bib44","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/00000542-200608000-00023","article-title":"Incidence of epidural hematoma, infection, and neurologic injury in obstetric patients with epidural analgesia\/anesthesia","volume":"105","author":"Ruppen","year":"2006","journal-title":"Anesthesiology"},{"issue":"5","key":"2026032411220695400_bib45","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3324\/haematol.2012.077263","article-title":"Principles of care for the diagnosis and treatment of von Willebrand disease","volume":"98","author":"Castaman","year":"2013","journal-title":"Haematologica"},{"issue":"5","key":"2026032411220695400_bib46","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1213\/ANE.0000000000005502","article-title":"Anesthetic management of von Willebrand disease in pregnancy: a retrospective analysis of a large case series","volume":"133","author":"Reale","year":"2021","journal-title":"Anesth Analg"},{"issue":"1","key":"2026032411220695400_bib47","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2516.2011.02573.x","article-title":"A systematic review: the use of desmopressin for treatment and prophylaxis of bleeding disorders in pregnancy","volume":"18","author":"Trigg","year":"2012","journal-title":"Haemophilia"},{"issue":"1","key":"2026032411220695400_bib48","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jtha.2023.09.021","article-title":"Desmopressin to prevent and treat bleeding in pregnant women with an inherited bleeding disorder: a systematic literature review","volume":"22","author":"Al Arashi","year":"2024","journal-title":"J Thromb Haemost"},{"issue":"17","key":"2026032411220695400_bib49","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1056\/NEJMoa2028788","article-title":"Tranexamic acid for the prevention of blood loss after cesarean delivery","volume":"384","author":"Sentilhes","year":"2021","journal-title":"N Engl J Med"},{"issue":"10084","key":"2026032411220695400_bib50","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0140-6736(17)30638-4","article-title":"Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial","volume":"389","author":"WOMAN Trial Collaborators","year":"2017","journal-title":"Lancet"},{"issue":"15","key":"2026032411220695400_bib51","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1056\/NEJMoa2207419","article-title":"Tranexamic acid to prevent obstetrical hemorrhage after cesarean delivery","volume":"388","author":"Pacheco","year":"2023","journal-title":"N Engl J Med"},{"issue":"8","key":"2026032411220695400_bib52","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJMoa1800942","article-title":"Tranexamic acid for the prevention of blood loss after vaginal delivery","volume":"379","author":"Sentilhes","year":"2018","journal-title":"N Engl J Med"},{"issue":"6","key":"2026032411220695400_bib53","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/hae.13067","article-title":"Obstetric bleeding among women with inherited bleeding disorders: a retrospective study","volume":"22","author":"Hawke","year":"2016","journal-title":"Haemophilia"},{"issue":"11","key":"2026032411220695400_bib54","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1182\/bloodadvances.2017005082","article-title":"Antifibrinolytic therapy for preventing VWD-related postpartum hemorrhage: indications and limitations","volume":"1","author":"Kouides","year":"2017","journal-title":"Blood Adv"},{"issue":"11","key":"2026032411220695400_bib55","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1210\/jc.2016-2118","article-title":"Hormonal replacement in hypopituitarism in adults: an Endocrine Society clinical practice guideline","volume":"101","author":"Fleseriu","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2026032411220695400_bib56","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1471-0528.2012.03282.x","article-title":"The spontaneous resolution of heavy menstrual bleeding in the perimenopausal years","volume":"119","author":"Shapley","year":"2012","journal-title":"BJOG"},{"issue":"1","key":"2026032411220695400_bib57","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijgo.2010.11.011","article-title":"FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age","volume":"113","author":"Munro","year":"2011","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"2026032411220695400_bib58","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0378-5122(95)00985-X","article-title":"The normal menopause transition: an overview","volume":"23","author":"McKinlay","year":"1996","journal-title":"Maturitas"},{"key":"2026032411220695400_bib59","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.thromres.2022.04.014","article-title":"Incidence and risk factors of venous thromboembolism in men and women","volume":"214","author":"Lind","year":"2022","journal-title":"Thromb Res"},{"key":"2026032411220695400_bib60","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2147\/IJWH.S288070","article-title":"Contraception during perimenopause: practical guidance","volume":"14","author":"Grandi","year":"2022","journal-title":"Int J Womens Health"},{"issue":"suppl 11","key":"2026032411220695400_bib61","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1586\/14737175.7.11s.S35","article-title":"Nomenclature and endocrinology of menopause and perimenopause","volume":"7","author":"Burger","year":"2007","journal-title":"Expert Rev Neurother"},{"issue":"11","key":"2026032411220695400_bib62","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1161\/ATVBAHA.123.319255","article-title":"Aging is associated with organ-specific alterations in the level and expression pattern of von Willebrand factor","volume":"43","author":"Alavi","year":"2023","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026032411220695400_bib63","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.thromres.2020.11.016","article-title":"Rise of levels of von Willebrand factor and factor VIII with age: role of genetic and acquired risk factors","volume":"197","author":"Biguzzi","year":"2021","journal-title":"Thromb Res"},{"issue":"1","key":"2026032411220695400_bib64","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/jth.15116","article-title":"Increasing levels of von Willebrand factor and factor VIII with age in patients affected by von Willebrand disease","volume":"19","author":"Biguzzi","year":"2021","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2026032411220695400_bib65","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1182\/bloodadvances.2021005430","article-title":"von Willebrand factor levels in the diagnosis of von Willebrand disease: a systematic review and meta-analysis","volume":"6","author":"Kalot","year":"2022","journal-title":"Blood Adv"},{"issue":"8","key":"2026032411220695400_bib66","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1055\/s-0040-1713636","article-title":"The effect of age on von Willebrand factor and bleeding symptoms in von Willebrand disease","volume":"120","author":"Seaman","year":"2020","journal-title":"Thromb Haemost"},{"issue":"14","key":"2026032411220695400_bib67","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1182\/blood.2023022457","article-title":"Type 1 VWD classification revisited: novel insights from combined analysis of the LoVIC and WiN studies","volume":"143","author":"Atiq","year":"2024","journal-title":"Blood"},{"issue":"6","key":"2026032411220695400_bib68","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1600-0609.2011.01611.x","article-title":"When von Willebrand disease comes into age - a matter of change?","volume":"86","author":"Miesbach","year":"2011","journal-title":"Eur J Haematol"},{"issue":"3","key":"2026032411220695400_bib69","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1177\/1076029617724232","article-title":"The association of aging with von Willebrand factor levels and bleeding risk in type 1 von Willebrand disease","volume":"24","author":"Seaman","year":"2018","journal-title":"Clin Appl Thromb Hemost"},{"issue":"4","key":"2026032411220695400_bib70","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1160\/TH12-04-0244","article-title":"Determinants of bleeding phenotype in adult patients with moderate or severe von Willebrand disease","volume":"108","author":"de Wee","year":"2012","journal-title":"Thromb Haemost"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/6\/2095\/2510218\/blooda_adv-2025-016486-c-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/6\/2095\/2510218\/blooda_adv-2025-016486-c-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T15:26:13Z","timestamp":1774365973000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/6\/2095\/557001\/The-interplay-of-von-Willebrand-disease-and-women"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":70,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,3,24]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025016486","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3,24]]},"published":{"date-parts":[[2026,3,24]]}}}